Luca Issi joined Bain Capital Life Sciences in 2017. Prior to joining Bain Capital, Dr. Issi worked in equity research at Cowen and Company. At Cowen, Dr. Issi was a member of the team covering the major pharmaceutical sector, where he developed financial forecasts and recommendations based on analysis of drug pipelines, clinical trials, therapeutics areas and corporate strategies. Prior to Cowen, Dr. Issi was an investment associate and content editor at BeaconVP Capital, where he performed fundamental research on small and mid-cap Biotech companies. As a scientist, Dr. Issi worked on the transcriptional circuits controlling virulence in infectious diseases.
Dr. Issi received his PhD in Biotechnology from Worcester Polytechnic Institute. He was also a collaborative researcher at the Broad Institute of Harvard and MIT and graduated summa cum laude in Biotechnology from the University of Milan (MS) and the University of Varese (BS).